Premium
Are published normal ranges of serum testosterone too high? Results of a cross‐sectional survey of serum testosterone and luteinizing hormone in healthy men
Author(s) -
Boyce Malcolm J.,
Baisley Kathy J.,
Clark Elizabeth V.,
Warrington Steven J.
Publication year - 2004
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2004.05051.x
Subject(s) - morning , evening , testosterone (patch) , luteinizing hormone , medicine , endocrinology , body mass index , free testosterone , hormone , sex hormone binding globulin , androgen , physics , astronomy
OBJECTIVE To derive normal ranges of serum testosterone and luteinizing hormone (LH) concentrations in healthy men, and thus evaluate whether testosterone replacement therapy is prescribed inappropriately. SUBJECTS AND METHODS The study comprised 266 healthy male volunteers (aged 18–75 years) who were defined as healthy by strict eligibility criteria. Subjects had a body mass index (BMI) of 18.6–32.2 kg/m 2 , smoked 0–10 cigarettes/day, and had an alcohol intake 0–40 units/week (one unit = 8 g ethanol). We measured serum testosterone and LH concentrations in the morning (08.00–09.00 hours) and evening (20.00–21.00 hours). RESULTS Morning normal ranges of testosterone for men aged ≤ 40 years were 10.07–38.76 nmol/L (2.90–11.18 µg/L), and for men age ≥ 40 years, 7.41–24.13 (2.14–6.96); the respective evening normal ranges were 6.69–31.51 (1.93–9.09) and 6.46–21.93 (1.86–6.33). Both morning and evening serum testosterone declined significantly with increasing age and BMI. LH was significantly higher in the morning than in the evening, but did not vary between the age groups or with BMI. The calculated normal ranges of LH were 0.9–7.0 IU/L (morning) and 0.7–6.8 IU/L (evening). CONCLUSIONS The lower limit of normal for serum testosterone was 3–4 nmol/L (0.86–1.15 µg/L) lower than that of published ranges. The results have important implications for the diagnosis of hypogonadism and use of testosterone replacement therapy.